Literature DB >> 25716172

Performance Evaluation of CLIA for Treponema Pallidum Specific Antibodies Detection in Comparison with ELISA.

Lixin Li1, Bei Cai1, Chuanmin Tao1, Lanlan Wang1.   

Abstract

OBJECTIVES: In this study we aimed to evaluate the performance effects of chemiluminescence assay (CLIA) for Treponema pallidum specific antibodies detection, and to compare T. pallidum specific antibodies detection accuracy between CLIA and ELISA with TPPA (T. pallidum particle agglutination assay) as a confirmatory test.
METHODS: A total of 865 samples from suspected syphilis patients and preoperative patients were included, in which T. pallidum specific antibodies were simultaneously detected by CLIA and ELISA. Among them, 457 samples were determined by TPPA.
RESULTS: All coefficients of variation (CVs) of ELISA in high-, median-, and low-level samples were more than 5% and the maximum CV was 54.39% in the low-level sample. CVs of CLIA in different-level samples were all below 5%. Among the three assays the Spearman correlation and Kappa coefficients were 0.771 (P ≤ 0.001) and 0.854 (P ≤ 0.001, CLIA vs. ELISA), 0.806 (P ≤ 0.001) and 0.897 (P ≤ 0.001, ELISA vs. TPPA), 0.937 (P ≤ 0.001) and 0.967 (P ≤ 0.001, CLIA vs. TPPA), respectively. The area under the receiver operating characteristic curve (AUC) of CLIA was higher than that of ELISA (0.994 vs. 0.989) with TPPA as the confirmatory test. In 18 discrepant samples the consistency rate between CLIA and TPPA was elevated compared with that between ELISA and TPPA (72.22% vs. 27.78%, P = 0.008). In gray zone, the consistency rate of CLIA with TPPA was higher than that of ELISA with TPPA (90.91% vs. 41.67%, P = 0.027).
CONCLUSIONS: Compared with ELISA, CLIA is more reliable, sensitive and accurate to detect serum T. pallidum specific antibodies. In the future it may be an alternative test with higher sensitivity to ELISA.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Treponema pallidum particle agglutination assay (TPPA); Treponema pallidum specific antibodies; chemiluminescence assay (CLIA); enzyme immunoassay (EIA); syphilis

Mesh:

Substances:

Year:  2015        PMID: 25716172      PMCID: PMC6807082          DOI: 10.1002/jcla.21839

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

1.  Evaluation of a chemiluminescent microparticle immunoassay for determination of Treponema pallidum antibodies.

Authors:  Nori Yoshioka; Matsuo Deguchi; Masanori Kagita; Mifumi Kita; Mikio Watanabe; Seishi Asari; Yoshinori Iwatani
Journal:  Clin Lab       Date:  2007       Impact factor: 1.138

2.  The Architect Syphilis assay for antibodies to Treponema pallidum: an automated screening assay with high sensitivity in primary syphilis.

Authors:  H Young; J Pryde; L Duncan; J Dave
Journal:  Sex Transm Infect       Date:  2008-09-12       Impact factor: 3.519

3.  Evaluation of a new competitive immunoassay (BioElisa Syphilis) for screening for Treponema pallidum antibodies at various stages of syphilis.

Authors:  A Ebel; L Bachelart; J M Alonso
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Treponema-specific tests for serodiagnosis of syphilis: comparative evaluation of seven assays.

Authors:  M J Binnicker; D J Jespersen; L O Rollins
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

5.  Treponema pallidum surface immunofluorescence assay for serologic diagnosis of syphilis.

Authors:  A Marangoni; V Sambri; E Storni; A D'Antuono; M Negosanti; R Cevenini
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

6.  Comparative evaluation of three different treponemal enzyme immunoassays for syphilis.

Authors:  Ronnachai Viriyataveekul; Nakornsak Laodee; Sumalee Potprasat; Sudarat Piyophirapong
Journal:  J Med Assoc Thai       Date:  2006-06

7.  Clinical comparison of the Treponema pallidum CAPTIA syphilis-G enzyme immunoassay with the fluorescent treponemal antibody absorption immunoglobulin G assay for syphilis testing.

Authors:  V W Halling; M F Jones; J E Bestrom; A D Wold; J E Rosenblatt; T F Smith; F R Cockerill
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Screening for treponemal infection by a new enzyme immunoassay.

Authors:  H Young; A Moyes; A McMillan; D H Robertson
Journal:  Genitourin Med       Date:  1989-04

9.  Serological diagnosis of syphilis: comparison of the Trep-Chek IgG enzyme immunoassay with other screening and confirmatory tests.

Authors:  Raymond S W Tsang; Irene E Martin; Allan Lau; Pam Sawatzky
Journal:  FEMS Immunol Med Microbiol       Date:  2007-10

10.  Evaluation of the LIAISON chemiluminescence immunoassay for diagnosis of syphilis.

Authors:  Carrie S Knight; Mary A Crum; Robert W Hardy
Journal:  Clin Vaccine Immunol       Date:  2007-04-25
View more
  7 in total

1.  Evaluation of the HISCL Anti-Treponema pallidum Assay as a Screening Test for Syphilis.

Authors:  Jingna An; Qixia Chen; Qianqian Liu; Chenli Rao; Dongdong Li; Tingting Wang; Chuanmin Tao; Lanlan Wang
Journal:  Clin Vaccine Immunol       Date:  2015-05-13

2.  Papulosquamous eruption with ocular symptoms caused by syphilis.

Authors:  Marcus G Tan; Mark G Kirchhof
Journal:  CMAJ       Date:  2020-12-07       Impact factor: 8.262

3.  Evaluation of the Lumipulse G TP-N Chemiluminescent Immunoassay as a Syphilis Screening Test.

Authors:  Daniel A Ortiz; Michael J Loeffelholz
Journal:  J Clin Microbiol       Date:  2017-09-06       Impact factor: 5.948

4.  Comparative Evaluation and Measure of Accuracy of ELISAs, CLIAs, and ECLIAs for the Detection of HIV Infection among Blood Donors in China.

Authors:  Le Chang; Junpeng Zhao; Fei Guo; Huimin Ji; Lu Zhang; Xinyi Jiang; Lunan Wang
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-08-14       Impact factor: 2.471

5.  Comparison of Roche Elecsys and Sysmex HISCL immunoassays for the screening of common blood-borne pathogens.

Authors:  Wanzhou Xu; Yongqing Tong; Yan Li
Journal:  Ann Transl Med       Date:  2019-07

6. 

Authors:  Marcus G Tan; Mark G Kirchhof
Journal:  CMAJ       Date:  2021-03-01       Impact factor: 8.262

7.  Performance characteristics of the Mindray chemiluminescence anti-Müllerian hormone assay.

Authors:  Jing-Jing Zhao; Chun-Min Kang; Peng Zhang; Lei Zheng
Journal:  J Clin Lab Anal       Date:  2021-03-04       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.